Detalhe da pesquisa
1.
Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infection.
Immunity
; 57(1): 40-51.e5, 2024 Jan 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38171362
2.
The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination.
Hepatology
; 57(2): 492-504, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23081796
3.
Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency.
J Clin Invest
; 132(15)2022 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35588376
4.
Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies.
J Virol
; 84(11): 5494-507, 2010 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-20237087
5.
Molecular Identification of Transmitted/Founder Hepatitis C Viruses and Their Progeny by Single Genome Sequencing.
Methods Mol Biol
; 1911: 139-155, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30593623
6.
High multiplicity infection following transplantation of hepatitis C virus-positive organs.
J Clin Invest
; 129(8): 3134-3139, 2019 05 21.
Artigo
Inglês
| MEDLINE | ID: mdl-31112523
7.
Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection.
Cell Host Microbe
; 24(5): 717-730.e5, 2018 11 14.
Artigo
Inglês
| MEDLINE | ID: mdl-30439341
8.
Corrigendum: Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation.
Front Vet Sci
; 4: 10, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28194402
9.
Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation.
Front Vet Sci
; 3: 99, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27909693
10.
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.
Nat Med
; 17(5): 589-95, 2011 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21516087